BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Din AU, Mazhar M, Waseem M, Ahmad W, Bibi A, Hassan A, Ali N, Gang W, Qian G, Ullah R, Shah T, Ullah M, Khan I, Nisar MF, Wu J. SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role. Biomed Pharmacother 2021;133:110947. [PMID: 33197765 DOI: 10.1016/j.biopha.2020.110947] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 26.5] [Reference Citation Analysis]
Number Citing Articles
1 Yao Y, Liu ZJ, Zhang YK, Sun HJ. Mechanism and potential treatments for gastrointestinal dysfunction in patients with COVID-19. World J Gastroenterol 2022; 28(48): 6811-6826 [DOI: 10.3748/wjg.v28.i48.6811] [Reference Citation Analysis]
2 Mazzarelli A, Giancola ML, Fontana A, Piselli P, Binda E, Trivieri N, Mencarelli G, Marchioni L, Vulcano A, De Giuli C, Panebianco C, Villani A, Copetti M, Perri F, Fontana C, Nicastri E, Pazienza V. Gut microbiota composition in COVID-19 hospitalized patients with mild or severe symptoms. Front Microbiol 2022;13:1049215. [PMID: 36560946 DOI: 10.3389/fmicb.2022.1049215] [Reference Citation Analysis]
3 Dzhulay GS, Dzhulay TE. Clinical and pathogenic features of COVID-19- associated diarrhea syndrome. jour 2022. [DOI: 10.31146/1682-8658-ecg-205-9-276-283] [Reference Citation Analysis]
4 Alenazy MF, Aljohar HI, Alruwaili AR, Daghestani MH, Alonazi MA, Labban RS, El-ansary AK, Balto HA. Gut Microbiota Dynamics in Relation to Long-COVID-19 Syndrome: Role of Probiotics to Combat Psychiatric Complications. Metabolites 2022;12:912. [DOI: 10.3390/metabo12100912] [Reference Citation Analysis]
5 Schmid DW, Fackelmann G, Wasimuddin, Rakotondranary J, Ratovonamana YR, Montero BK, Ganzhorn JU, Sommer S. A framework for testing the impact of co-infections on host gut microbiomes. anim microbiome 2022;4:48. [DOI: 10.1186/s42523-022-00198-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ionita Radu F, Department of Internal medicine and Gastroenterology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania, Sirbu CA, Docu Axelerad A, Stefan I, Department of Neurology, Carol Davila Central Military Emergency University Hospital, Bucharest, Romania, Department of Neurology, Clinical Emergency Hospital ‘St. Apostol Andrei’, Constanta, Romania, 4 Department, Faculty of Medicine, ‘Ovidius’ University of Constanta, Department of medico-surgical and prophylactic disciplines, Titu Maiorescu University, Bucharest, Romania, Department of Infectious Diseases, Carol Davila University Central Emergency Military Hospital, Bucharest, Romania. Gut microbiota and obesity. RJMM 2022;125:464-468. [DOI: 10.55453/rjmm.2022.125.3.16] [Reference Citation Analysis]
7 Liu S, Zhao Y, Feng X, Xu H. SARS-CoV-2 infection threatening intestinal health: A review of potential mechanisms and treatment strategies. Crit Rev Food Sci Nutr 2022;:1-19. [PMID: 35894645 DOI: 10.1080/10408398.2022.2103090] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Aldhafiri FK. Dietary supplements and nutraceuticals in the recovery of COVID-19: A systematic review and meta-analysis. Nutrition Clinique et Métabolisme 2022. [DOI: 10.1016/j.nupar.2022.07.001] [Reference Citation Analysis]
9 Fakhruddin KS, Samaranayake LP, Buranawat B, Ngo H. Oro-facial mucocutaneous manifestations of Coronavirus Disease-2019 (COVID-19): A systematic review. PLoS ONE 2022;17:e0265531. [DOI: 10.1371/journal.pone.0265531] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Alharbi KS, Singh Y, Hassan Almalki W, Rawat S, Afzal O, Alfawaz Altamimi AS, Kazmi I, Al-Abbasi FA, Alzarea SI, Singh SK, Bhatt S, Chellappan DK, Dua K, Gupta G. Gut Microbiota Disruption in COVID-19 or Post-COVID Illness Association with severity biomarkers: A Possible Role of Pre / Pro-biotics in manipulating microflora. Chem Biol Interact 2022;358:109898. [PMID: 35331679 DOI: 10.1016/j.cbi.2022.109898] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Xu L, Yang CS, Liu Y, Zhang X. Effective Regulation of Gut Microbiota With Probiotics and Prebiotics May Prevent or Alleviate COVID-19 Through the Gut-Lung Axis. Front Pharmacol 2022;13:895193. [DOI: 10.3389/fphar.2022.895193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wang Z, Bai C, Hu T, Luo C, Yu H, Ma X, Liu T, Gu X. Emerging trends and hotspot in gut-lung axis research from 2011 to 2021: a bibliometrics analysis. Biomed Eng Online 2022;21:27. [PMID: 35449051 DOI: 10.1186/s12938-022-00987-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Farsi Y, Tahvildari A, Arbabi M, Vazife F, Sechi LA, Shahidi Bonjar AH, Jamshidi P, Nasiri MJ, Mirsaeidi M. Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review. Front Cell Infect Microbiol 2022;12:804644. [DOI: 10.3389/fcimb.2022.804644] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
14 Li J, Yang Y, Xiong B, Lu J, Zhou Y, Li C, Hu X. The immunomodulatory effects of Qushi Jianpi Hewei Decoction (QJHD) for patients with COVID-19 by metagenomics and transcriptomic sequencing. Pharmacological Research - Modern Chinese Medicine 2022;2:100049. [DOI: 10.1016/j.prmcm.2022.100049] [Reference Citation Analysis]
15 Ortega-peña S, Rodríguez-martínez S, Cancino-diaz ME, Cancino-diaz JC. Staphylococcus epidermidis Controls Opportunistic Pathogens in the Nose, Could It Help to Regulate SARS-CoV-2 (COVID-19) Infection? Life 2022;12:341. [DOI: 10.3390/life12030341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Odun-ayo F, Reddy L. Gastrointestinal Microbiota Dysbiosis Associated with SARS-CoV-2 Infection in Colorectal Cancer: The Implication of Probiotics. Gastroenterology Insights 2022;13:35-59. [DOI: 10.3390/gastroent13010006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
17 Aldhafiri FK. COVID-19 and gut dysbiosis, understanding the role of probiotic supplements in reversing gut dysbiosis and immunity. Nutrition Clinique et Métabolisme 2022. [DOI: 10.1016/j.nupar.2022.01.003] [Reference Citation Analysis]
18 Zhou T, Wu J, Zeng Y, Li J, Yan J, Meng W, Han H, Feng F, He J, Zhao S, Zhou P, Wu Y, Yang Y, Han R, Jin W, Li X, Yang Y, Li X. SARS‐CoV‐2 triggered oxidative stress and abnormal energy metabolism in gut microbiota. MedComm 2022;3:41-56. [DOI: 10.1002/mco2.112] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
19 Xavier-Santos D, Padilha M, Fabiano GA, Vinderola G, Gomes Cruz A, Sivieri K, Costa Antunes AE. Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review. Trends Food Sci Technol 2022;120:174-92. [PMID: 35002079 DOI: 10.1016/j.tifs.2021.12.033] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 16.0] [Reference Citation Analysis]
20 Szychowiak P, Villageois-Tran K, Patrier J, Timsit JF, Ruppé É. The role of the microbiota in the management of intensive care patients. Ann Intensive Care 2022;12:3. [PMID: 34985651 DOI: 10.1186/s13613-021-00976-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
21 Thipe VC, Mentor S, Lima CS, Freitas LF, Fonseca AC, Nogueira KM, Rodrigues AS, Batista JG, Ferreira AH, Lugão AB. The role of probiotics in maintaining immune homeostasis. Probiotics in the Prevention and Management of Human Diseases 2022. [DOI: 10.1016/b978-0-12-823733-5.00024-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Muthuirulan P, Bandyopadhyay M, Mamillapalli S, Sharma P. Unlocking the Mysteries of the Human Microbiome to Combat COVID-19. Human Microbiome 2022. [DOI: 10.1007/978-981-16-7672-7_11] [Reference Citation Analysis]
23 Ventero MP, Moreno-Perez O, Molina-Pardines C, Paytuví-Gallart A, Boix V, Escribano I, Galan I, González-delaAleja P, López-Pérez M, Sánchez-Martínez R, Merino E, Rodríguez JC. Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients: a retrospective cohort study in a Mediterranean area. J Infect 2021:S0163-4453(21)00647-2. [PMID: 34963638 DOI: 10.1016/j.jinf.2021.12.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Pinto G, Lima L, Pedra T, Assumpção A, Morgado S, Mascarenhas L. Bloodstream infection by Saccharomyces cerevisiae in a COVID-19 patient receiving probiotic supplementation in the ICU in Brazil. Access Microbiol 2021;3:000250. [PMID: 34888480 DOI: 10.1099/acmi.0.000250] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
25 Settanni CR, Ianiro G, Ponziani FR, Bibbò S, Segal JP, Cammarota G, Gasbarrini A. COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms. World J Gastroenterol 2021; 27(43): 7433-7445 [PMID: 34887641 DOI: 10.3748/wjg.v27.i43.7433] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
26 Zhou T, Zeng Y, Wu J, Li J, Yan J, Meng W, Han H, Feng F, He J, Zhao S, Zhou P, Wu Y, Yang Y, Han R, Jin W, Li X, Yang Y, Li X. SARS-CoV-2 triggered excessive inflammation and abnormal energy metabolism in gut microbiota.. [DOI: 10.1101/2021.11.08.467715] [Reference Citation Analysis]
27 Zhu Z, Zhang S, Wang P, Chen X, Bi J, Cheng L, Zhang X. A comprehensive review of the analysis and integration of omics data for SARS-CoV-2 and COVID-19. Brief Bioinform 2021:bbab446. [PMID: 34718395 DOI: 10.1093/bib/bbab446] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Youssef M, Ahmed HY, Zongo A, Korin A, Zhan F, Hady E, Umair M, Shahid Riaz Rajoka M, Xiong Y, Li B. Probiotic Supplements: Their Strategies in the Therapeutic and Prophylactic of Human Life-Threatening Diseases. Int J Mol Sci 2021;22:11290. [PMID: 34681948 DOI: 10.3390/ijms222011290] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
29 Averina OV, Poluektova EU, Marsova MV, Danilenko VN. Biomarkers and Utility of the Antioxidant Potential of Probiotic Lactobacilli and Bifidobacteria as Representatives of the Human Gut Microbiota. Biomedicines 2021;9:1340. [PMID: 34680457 DOI: 10.3390/biomedicines9101340] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
30 Ventero MP, Moreno-perez O, Molina-pardines C, Paytuví-gallart A, Boix V, Galan I, González-delaaleja P, López-pérez M, Sánchez-martínez R, Merino E, Rodríguez JC. Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients: a retrospective cohort study in a Mediterranean area.. [DOI: 10.1101/2021.09.28.461924] [Reference Citation Analysis]
31 Wassenaar TM, Juncos VA, Zimmermann K. Interactions between the Gut Microbiome, Lung Conditions, and Coronary Heart Disease and How Probiotics Affect These. Int J Mol Sci 2021;22:9700. [PMID: 34575864 DOI: 10.3390/ijms22189700] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Gromova OA, Torshin IY, Chuchalin AG, Maksimov VA. Microbiome, probiotics, and COVID-19: promising approaches to support innate and acquired immunity systems. jour 2021. [DOI: 10.31146/1682-8658-ecg-188-4-68-75] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Hong BS, Kim MR. Interplays between human microbiota and microRNAs in COVID-19 pathogenesis: a literature review. Phys Act Nutr 2021;25:1-7. [PMID: 34315200 DOI: 10.20463/pan.2021.0008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
34 Calitri C, Fumi I, Ignaccolo MG, Banino E, Benetti S, Lupica MM, Fantone F, Pace M, Garofalo F. Gastrointestinal involvement in paediatric COVID-19 — from pathogenesis to clinical management: A comprehensive review. World J Gastroenterol 2021; 27(23): 3303-3316 [PMID: 34163113 DOI: 10.3748/wjg.v27.i23.3303] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
35 Peng J, Zhang M, Yao G, Kwok LY, Zhang W. Probiotics as Adjunctive Treatment for Patients Contracted COVID-19: Current Understanding and Future Needs. Front Nutr 2021;8:669808. [PMID: 34179059 DOI: 10.3389/fnut.2021.669808] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
36 Katz-Agranov N, Zandman-Goddard G. Autoimmunity and COVID-19 - The microbiotal connection. Autoimmun Rev 2021;20:102865. [PMID: 34118455 DOI: 10.1016/j.autrev.2021.102865] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
37 Strauss M, Mičetić-Turk D, Pogačar MŠ, Fijan S. Probiotics for the Prevention of Acute Respiratory-Tract Infections in Older People: Systematic Review. Healthcare (Basel) 2021;9:690. [PMID: 34200435 DOI: 10.3390/healthcare9060690] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
38 Kvakova M, Bertkova I, Stofilova J, Savidge TC. Co-Encapsulated Synbiotics and Immobilized Probiotics in Human Health and Gut Microbiota Modulation. Foods 2021;10:1297. [PMID: 34200108 DOI: 10.3390/foods10061297] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
39 Battaglini D, Robba C, Fedele A, Trancǎ S, Sukkar SG, Di Pilato V, Bassetti M, Giacobbe DR, Vena A, Patroniti N, Ball L, Brunetti I, Torres Martí A, Rocco PRM, Pelosi P. The Role of Dysbiosis in Critically Ill Patients With COVID-19 and Acute Respiratory Distress Syndrome. Front Med (Lausanne) 2021;8:671714. [PMID: 34150807 DOI: 10.3389/fmed.2021.671714] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
40 K NK, Patil P, Bhandary SK, Haridas V, N SK, E S, Shetty P. Is butyrate a natural alternative to dexamethasone in the management of CoVID-19? F1000Res 2021;10:273. [PMID: 34046165 DOI: 10.12688/f1000research.51786.1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
41 Cámara M, Sánchez-Mata MC, Fernández-Ruiz V, Cámara RM, Cebadera E, Domínguez L. A Review of the Role of Micronutrients and Bioactive Compounds on Immune System Supporting to Fight against the COVID-19 Disease. Foods 2021;10:1088. [PMID: 34068930 DOI: 10.3390/foods10051088] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
42 Fuentes-Chust C, Parolo C, Rosati G, Rivas L, Perez-Toralla K, Simon S, de Lecuona I, Junot C, Trebicka J, Merkoçi A. The Microbiome Meets Nanotechnology: Opportunities and Challenges in Developing New Diagnostic Devices. Adv Mater 2021;33:e2006104. [PMID: 33719117 DOI: 10.1002/adma.202006104] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
43 Al-Beltagi M, Saeed NK, Bediwy AS, El-Sawaf Y. Paediatric gastrointestinal disorders in SARS-CoV-2 infection: Epidemiological and clinical implications. World J Gastroenterol 2021;27:1716-27. [PMID: 33967552 DOI: 10.3748/wjg.v27.i16.1716] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
44 Al-Beltagi M, Saeed NK, Bediwy AS, El-Sawaf Y. Paediatric gastrointestinal disorders in SARS-CoV-2 infection: Epidemiological and clinical implications. World J Gastroenterol 2021;27:1716-27. [PMID: 33967552 DOI: 10.3748/wjg.v27.i16.1716] [Reference Citation Analysis]
45 Lv L, Gu S, Jiang H, Yan R, Chen Y, Chen Y, Luo R, Huang C, Lu H, Zheng B, Zhang H, Xia J, Tang L, Sheng G, Li L. Gut mycobiota alterations in patients with COVID-19 and H1N1 infections and their associations with clinical features. Commun Biol 2021;4:480. [PMID: 33850296 DOI: 10.1038/s42003-021-02036-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 14.5] [Reference Citation Analysis]
46 Chattopadhyay I, Shankar EM. SARS-CoV-2-Indigenous Microbiota Nexus: Does Gut Microbiota Contribute to Inflammation and Disease Severity in COVID-19? Front Cell Infect Microbiol 2021;11:590874. [PMID: 33791231 DOI: 10.3389/fcimb.2021.590874] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
47 Li Q, Cheng F, Xu Q, Su Y, Cai X, Zeng F, Zhang Y. The role of probiotics in coronavirus disease-19 infection in Wuhan: A retrospective study of 311 severe patients. Int Immunopharmacol 2021;95:107531. [PMID: 33714884 DOI: 10.1016/j.intimp.2021.107531] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
48 Darbandi A, Asadi A, Ghanavati R, Afifirad R, Darb Emamie A, Kakanj M, Talebi M. The effect of probiotics on respiratory tract infection with special emphasis on COVID-19: Systemic review 2010-20. Int J Infect Dis 2021;105:91-104. [PMID: 33578007 DOI: 10.1016/j.ijid.2021.02.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
49 Rueda Ruzafa L, Cedillo JL, Hone AJ. Nicotinic Acetylcholine Receptor Involvement in Inflammatory Bowel Disease and Interactions with Gut Microbiota. Int J Environ Res Public Health 2021;18:1189. [PMID: 33572734 DOI: 10.3390/ijerph18031189] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
50 Chirumbolo S, Franzini M, Simonetti V, Valdenassi L, Ricevuti G, Bertossi D, Pandolfi S. Oxygen-ozone autohemotherapy against COVID-19 needs to fit highly experienced, customized, and standardized protocols to succeed. J Med Virol 2021;93:2580-2. [PMID: 33503267 DOI: 10.1002/jmv.26806] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Ezechukwu HC, Diya CA, Egoh IJ, Abiodun MJ, Grace JA, Okoh GR, Adu KT, Adegboye OA. Lung microbiota dysbiosis and the implications of SARS-CoV-2 infection in pregnancy. Ther Adv Infect Dis 2021;8:20499361211032453. [PMID: 35035953 DOI: 10.1177/20499361211032453] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Shehata AA, Parvin R, Nagy A, Wang Y, Azhar TM, Attia YA, Azhar EI, Paul AK, Rahmatullah M. An overview of the ongoing challenges in SARS-CoV-2 global control. Ger J Microbiol 2021;1:1-18. [DOI: 10.51585/gjm.2021.2.0006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]